TH23665B - A new solution for wound healing and skin hygiene. - Google Patents

Abstract

Prior to the invention of DC60, which is the subject of this patent application, the treatment of various wounds, such as fresh wounds, infected wounds, and chronic wounds, generally involved daily wound cleaning with alcohol or hydrogen peroxide (which, in fact, has very little antiseptic effect but is more effective at killing fungal spores than bacteria, even at low concentrations, and can still damage tissue). This was followed by the application of antiseptic solutions containing iodine (which can severely irritate the skin) and the application of topical antibiotics. However, it is widely known that iodine is a strong oxidizing agent that can irritate and destroy the cell walls of tissues and bacteria, resulting in swelling and inflammation in the wound, thus slowing down the healing process. Furthermore, before the invention of this patent application, the treatment of infected wounds typically involved taking prescribed medication along with daily wound cleaning as recommended by a doctor. The inventor discovered a substance that is bioacceptable and safe, even for the most delicate tissues. This allows for effective treatment of various wounds and skin infections mentioned above, without the need for wound covering or the use of any topical medications. This is despite the fact that some of the aforementioned wounds were almost incurable before the invention. The new invention may be presented as a clear liquid or a concentrated solution that can be diluted to different concentrations with various media or carriers to achieve a ready-to-use state. These solutions may be available in various forms such as gel, salve, lotion, wet pads, wet foam, ointment, stick, roll-on, dry mixture with solution, and facial masks. Their purpose is to cleanse, disinfect, and inhibit infection, while also accelerating the natural healing process of various wounds, including fresh cuts, surgical stitches, chronic wounds, necrotic wounds from diabetes, acute wounds, herpes zoster, athletic foot, and bedsores. Importantly, after using these solutions, it is not necessary to constantly bandage or cover the wound with plaster. Furthermore, it does not require the use of any topical medications. In addition, this solution can be used to treat other conditions such as acne and ear infections. The treatment process of this novel formula includes the ability to induce natural exfoliation of dead skin tissue (autolytic debridement), re-epithelialization of skin tissue, granulation of tissues, and remodeling/maturation of tissues in the wound area. Besides promoting rapid wound healing, the formula also inhibits bacterial growth in the wound and helps prevent unpleasant odors often associated with chronic diabetic wounds. Prior to the invention of this patent application, wound treatment for various wounds, such as fresh wounds, infected wounds, and chronic wounds, generally involved daily wound cleaning with alcohol or hydrogen peroxide (which, in reality, has very little antiseptic effect but is more effective at killing fungi in the form of spores than at killing bacteria, even at low concentrations, and can still damage tissue). Wound dressings containing iodine were also applied. (which can be severely irritating to the skin) followed by the application of topical antibiotics to the wound. However, it is widely known that iodine is a strong oxidizing agent that can irritate the cell walls of tissues and destroy the cell walls of bacteria, resulting in swelling and inflammation in the wound tissue, thus slowing down the body's wound healing process. Furthermore, before the invention of this patented substance, the treatment of infected wounds usually involved taking prescribed medication along with daily wound cleaning as recommended by a doctor. The inventors discovered a substance that is bioacceptable and safe, even for the most delicate tissues, allowing it to be effectively used on various wounds and skin infections mentioned above without the need for wound covering or the use of any topical medications. This is despite the fact that some of the wounds mentioned above were almost incurable before this new invention. The new invention may be presented as a clear liquid or a concentrated solution that can be diluted to different concentrations with various media or carriers to achieve a ready-to-use state. These solutions may be available in various forms such as gel, salve, lotion, wet pads, wet foam, ointment, stick, roll-on, dry mixture with solution, and facial masks. Their purpose is to cleanse, disinfect, and inhibit infection, while also accelerating the natural healing process of various wounds, including fresh cuts, surgical stitches, chronic wounds, necrotic wounds from diabetes, acute wounds, herpes zoster, athletic foot, and bedsores. Importantly, after using these solutions, it is not necessary to constantly bandage or cover the wound with plaster. Furthermore, it does not require the use of any topical medications. In addition, this solution can be used to treat other conditions such as acne and ear infections. The treatment process of this innovative formula includes the ability to induce natural exfoliation of dead skin tissue (autolytic debridement), re-epithelialization of skin tissue, granulation of tissues, and remodeling/maturation of tissues in the wound area. Besides promoting rapid wound healing, the formula also inhibits bacterial growth in the wound and helps prevent unpleasant odors often associated with chronic diabetic wounds.

Claims (14)

1. The composition of skin hygiene solutions includes sodium hypochlorite 0.025-0.125% by weight of the total weight of the components, sodium chloride 1-30% by weight of the total weight of the components, and sulfur from sulfate salts at a concentration of 10-350 PPM. 2. The composition under Recollection 1 where such sulfate salts may be either organic or inorganic minerals such as sodium, magnesium, potassium, zinc, iron, iodine, copper, selenium and/or sulfur from sulfate salts, and more than one such sulfate salt may be used. 3. Any component under claims 1-2, where there is another compound with antiseptic, antifungal, antimycotic, dermatological, and/or light-absorbent substance activity. 4. Any one of the components under claims 1-3, where there is another active compound which is a herbal extract derived from roots, leaves, algae, and/or herbal oils. 5. Any one of the components under claims 1-4, where the other active compound used is a pH adjuster and/or pH stabilizer. 6. Any one of the components under claims 1-5, where other active compounds are used, namely: preservatives, detergents, surfactants, zinc oxide, skin protectants, bleaching agents, oxidizing agents, soothing agents, sudsing agents, and pH adjusters. 7. Any one of the components under claims 1-6, in the presence of another active compound, is used as an osmolarity regulator, glycerine, an osmotic adjuster, a tissue granulation stimulator, and/or astringent inducing and/or cell proliferation stimulator. 8. Any one of the components under claims 1-7, where there is another active compound used as an anti-inflammatory, antiviral, antibiotic, antioxidant, organic acid, biofermented product from microorganism, mineral acid (Fulvic Acid, Humic Acid), antifungal, and/or other pharmaceutically acceptable antimicrobial agent. 9. Any of the components under claims 1-8, where another active compound used is an amino acid, vitamin, and/or mineral. 10. Any one of the components under claims 1-9, where another active compound is used, namely beta glucan and/or keratine derivatives. 11. Any of the components under Requirements 1-10, where the solution is concentrated to the point where it can be diluted to a lower concentration or converted into a greaseless gel-water product, a soluble or salve, a lotion, a wet pad, a cream, a roll-on, a pentrolatum-based ointment, or an emulsion-based or foam-based preparation. 12. Any of the components of claims 1-10, where they are manufactured into moistened towelettes, sticks, or powders for mixing with water for further use. 13. Any of the elements under claims 1-10, where they are applied to plasters or gauze. 14. Any of the components under claims 1-10, where they are used as an antiseptic for fresh wounds, purulent wounds, chronic wounds, surgical and sutured wounds, bedsores, herpes zoster, itchy skin and intercostal ulcers, eye drops, ear drops for infections, nasal drops, nasal sprays, eye washes, vaginal and anal washes, and deodorants for external skin hygiene.